Biogen Inc.
BIIB
Cena:
$ 193.76
+4.29 (2.26%)
Valuace
35
Růst
0
Zdraví
85
Akcionáři
Akcionáři společnosti
Insider trading
Akcionáři společnosti
| Držitel | Počet akcií | Podíl společnosti | Změna % | Váha pozice v portfoliu | Prvně nakoupeno |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 17.4 mil | 11.89% | 0.01% | 0.04% | 2005-03-31 |
| BLACKROCK, INC. | 16.0 mil | 10.89% | 0.01% | 0.05% | 2024-09-30 |
| BLACKROCK FUNDING, INC. /DE | 15.5 mil | 10.62% | -0.01% | 0.05% | 2024-09-30 |
| PRIMECAP MANAGEMENT CO/CA/ | 14.8 mil | 10.06% | 0.16% | 2.13% | 2003-12-31 |
| BLACKROCK INC. | 14.5 mil | 10.01% | 0.01% | 0.08% | 2013-06-30 |
| FMR LLC | 12.8 mil | 8.73% | 0.04% | 0.12% | 2008-09-30 |
| STATE STREET CORP | 7.2 mil | 4.89% | 0.00% | 0.05% | 2013-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 4.3 mil | 2.96% | 0.00% | 0.05% | 2006-09-30 |
| WELLINGTON MANAGEMENT GROUP LLP | 3.0 mil | 2.02% | -0.01% | 0.10% | 2005-12-31 |
| NORGES BANK | 2.6 mil | 1.80% | 0.05% | 0.05% | 2025-12-31 |
| MORGAN STANLEY | 2.2 mil | 1.48% | 0.00% | 0.02% | 2013-06-30 |
| JPMORGAN CHASE & CO | 2.0 mil | 1.37% | 0.00% | 0.02% | 2013-06-30 |
| AQR CAPITAL MANAGEMENT LLC | 1.9 mil | 1.31% | 0.02% | 0.16% | 2003-12-31 |
| BEUTEL, GOODMAN & CO LTD. | 1.7 mil | 1.20% | -0.21% | 1.45% | 2021-03-31 |
| INVESCO LTD. | 1.7 mil | 1.19% | 0.00% | 0.05% | 2011-12-31 |
| BOSTON PARTNERS | 1.7 mil | 1.16% | 0.01% | 0.33% | 2025-12-31 |
| NORTHERN TRUST CORP | 1.4 mil | 0.99% | 0.00% | 0.04% | 2013-06-30 |
| UBS ASSET MANAGEMENT AMERICAS INC | 1.4 mil | 0.94% | 0.00% | 0.05% | 2003-12-31 |
| LEGAL & GENERAL GROUP PLC | 1.3 mil | 0.92% | 0.00% | 0.06% | 2007-06-30 |
| RA CAPITAL MANAGEMENT, L.P. | 1.2 mil | 0.81% | -0.36% | 2.65% | 2022-03-31 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 1.2 mil | 0.79% | 0.02% | 0.15% | 2023-06-30 |
| AMERIPRISE FINANCIAL INC | 1.2 mil | 0.79% | -0.03% | 0.06% | 2012-03-31 |
| BANK OF AMERICA CORP /DE/ | 1.2 mil | 0.79% | 0.00% | 0.02% | 2013-03-31 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.1 mil | 0.78% | 0.00% | 0.03% | 2003-12-31 |
| PACER ADVISORS, INC. | 1.1 mil | 0.78% | 0.00% | 0.52% | 2015-12-31 |
| MILLENNIUM MANAGEMENT LLC | 1.1 mil | 0.77% | 0.02% | 0.08% | 2007-06-30 |
| VAN ECK ASSOCIATES CORP | 1.1 mil | 0.74% | -0.01% | 0.15% | 2011-12-31 |
| DIMENSIONAL FUND ADVISORS LP | 1.1 mil | 0.74% | 0.01% | 0.04% | 2013-06-30 |
| DEUTSCHE BANK AG\ | 1.1 mil | 0.73% | 0.01% | 0.06% | 2013-09-30 |
| GOLDMAN SACHS GROUP INC | 1.1 mil | 0.72% | 0.00% | 0.02% | 2007-12-31 |
| RENAISSANCE TECHNOLOGIES LLC | 964.41 tis | 0.66% | 0.00% | 0.18% | 2010-06-30 |
| MAN GROUP PLC | 918.03 tis | 0.63% | 0.03% | 0.22% | 2018-03-31 |
| PICTET ASSET MANAGEMENT HOLDING SA | 913.33 tis | 0.62% | 0.02% | 0.18% | 2023-09-30 |
| MARSHALL WACE, LLP | 887.66 tis | 0.61% | 0.10% | 0.13% | 2024-03-31 |
| AMERICAN CENTURY COMPANIES INC | 821.30 tis | 0.57% | 0.00% | 0.12% | 2013-06-30 |
| VANGUARD FIDUCIARY TRUST CO | 825.53 tis | 0.56% | 0.04% | 0.04% | 2026-03-31 |
| POINT72 ASSET MANAGEMENT, L.P. | 809.62 tis | 0.55% | -0.36% | 0.19% | 2025-03-31 |
| ALYESKA INVESTMENT GROUP, L.P. | 805.05 tis | 0.55% | -0.09% | 0.42% | 2025-06-30 |
| FIL LTD | 790.61 tis | 0.54% | 0.03% | 0.18% | 2019-12-31 |
| AMUNDI | 790.83 tis | 0.54% | 0.01% | 0.04% | 2021-06-30 |
| BANK OF NEW YORK MELLON CORP | 788.52 tis | 0.54% | 0.00% | 0.03% | 2009-09-30 |
| ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V. | 763.17 tis | 0.52% | 0.05% | 0.20% | 2007-09-30 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 743.31 tis | 0.51% | -0.10% | 0.09% | 2020-03-31 |
| FRED ALGER MANAGEMENT, LLC | 733.19 tis | 0.50% | 0.04% | 0.59% | 2025-03-31 |
| SG AMERICAS SECURITIES, LLC | 719.79 tis | 0.49% | 0.32% | 0.32% | 2013-06-30 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 720.63 tis | 0.49% | 0.00% | 0.04% | 2013-06-30 |
| 704.20 tis | 0.48% | 0.06% | 0.98% | 2021-09-30 | |
| FIRST TRUST ADVISORS LP | 673.96 tis | 0.46% | 0.02% | 0.09% | 2013-06-30 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 672.43 tis | 0.46% | 0.00% | 0.01% | 2007-06-30 |
| BALYASNY ASSET MANAGEMENT L.P. | 650.05 tis | 0.44% | 0.02% | 0.15% | 2020-09-30 |
| SARISSA CAPITAL MANAGEMENT LP | 643.00 tis | 0.44% | 0.91% | 25.16% | 2015-12-31 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 624.37 tis | 0.43% | 0.03% | 0.06% | 2025-03-31 |
| AUSTRALIANSUPER PTY LTD | 616.19 tis | 0.42% | 0.20% | 0.59% | 2025-03-31 |
| CLEARBRIDGE INVESTMENTS, LLC | 601.99 tis | 0.41% | -0.18% | 0.09% | 2011-09-30 |
| FRANKLIN RESOURCES INC | 588.12 tis | 0.40% | 0.01% | 0.02% | 2013-06-30 |
| ARTEMIS INVESTMENT MANAGEMENT LLP | 571.57 tis | 0.39% | 0.63% | 1.11% | 2025-12-31 |
| BARCLAYS PLC | 551.47 tis | 0.38% | -0.03% | 0.02% | 2013-06-30 |
| ABRDN PLC | 543.41 tis | 0.37% | -0.05% | 0.15% | 2017-09-30 |
| ROYAL BANK OF CANADA | 531.38 tis | 0.36% | 0.00% | 0.02% | 2013-06-30 |
| ALLIANZ ASSET MANAGEMENT GMBH | 527.06 tis | 0.36% | -0.04% | 0.08% | 2013-06-30 |
| UBS GROUP AG | 523.45 tis | 0.36% | 0.00% | 0.01% | 2014-12-31 |
| ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | 522.16 tis | 0.36% | 0.04% | 0.21% | 2011-12-31 |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 521.10 tis | 0.36% | 0.21% | 1.26% | 2024-12-31 |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC | 518.69 tis | 0.35% | -0.02% | 0.15% | 2025-03-31 |
| ORBIMED ADVISORS LLC | 509.10 tis | 0.35% | -1.27% | 1.61% | 2006-12-31 |
| TWO SIGMA INVESTMENTS, LP | 507.54 tis | 0.35% | -0.14% | 0.11% | 2021-03-31 |
| CITIGROUP INC | 500.51 tis | 0.34% | -0.01% | 0.04% | 2003-12-31 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 495.20 tis | 0.34% | 0.00% | 0.01% | 2013-06-30 |
| D. E. SHAW & CO., INC. | 477.92 tis | 0.33% | -0.08% | 0.04% | 2008-09-30 |
| BNP PARIBAS ARBITRAGE, SNC | 471.07 tis | 0.32% | 0.00% | 0.04% | 2013-06-30 |
| WORLDQUANT MILLENNIUM ADVISORS LLC | 461.12 tis | 0.32% | 0.25% | 0.46% | 2023-09-30 |
| HSBC HOLDINGS PLC | 463.65 tis | 0.32% | 0.00% | 0.04% | 2012-03-31 |
| TWO SIGMA ADVISERS, LP | 455.50 tis | 0.31% | -0.09% | 0.12% | 2021-09-30 |
| PRUDENTIAL FINANCIAL INC | 439.11 tis | 0.30% | 0.01% | 0.07% | 2004-12-31 |
| SWISS NATIONAL BANK | 430.60 tis | 0.29% | 0.00% | 0.05% | 2013-06-30 |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 414.83 tis | 0.28% | -0.01% | 0.03% | 2011-06-30 |
| AXA S.A. | 407.84 tis | 0.28% | -0.11% | 0.26% | 2013-06-30 |
| CITADEL ADVISORS LLC | 407.00 tis | 0.28% | 0.01% | 0.01% | 2016-09-30 |
| CAMBER CAPITAL MANAGEMENT LP | 400.00 tis | 0.28% | 2.11% | 2.11% | 2024-03-31 |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 399.40 tis | 0.27% | -0.07% | 0.19% | 2013-06-30 |
| NATIONAL PENSION SERVICE | 401.67 tis | 0.27% | 0.02% | 0.06% | 2014-09-30 |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 397.85 tis | 0.27% | -0.01% | 0.04% | 2013-06-30 |
| PALO ALTO INVESTORS LP | 380.42 tis | 0.26% | -0.40% | 8.87% | 2020-12-31 |
| CANDRIAM S.C.A. | 381.77 tis | 0.26% | 0.07% | 0.36% | 2014-12-31 |
| PATIENT CAPITAL MANAGEMENT, LLC | 379.74 tis | 0.26% | -1.37% | 2.55% | 2024-03-31 |
| TD ASSET MANAGEMENT INC | 371.00 tis | 0.25% | -0.02% | 0.06% | 2013-06-30 |
| PARNASSUS INVESTMENTS, LLC | 361.51 tis | 0.25% | -0.03% | 0.15% | 2021-03-31 |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 358.99 tis | 0.25% | -0.03% | 0.01% | 2022-12-31 |
| BROWN ADVISORY INC | 333.23 tis | 0.23% | -0.02% | 0.08% | 2011-06-30 |
| NUVEEN ASSET MANAGEMENT, LLC | 321.31 tis | 0.22% | 0.00% | 0.02% | 2012-12-31 |
| SQUAREPOINT OPS LLC | 314.71 tis | 0.22% | 0.07% | 0.12% | 2016-12-31 |
| POLAR CAPITAL HOLDINGS PLC | 300.00 tis | 0.21% | -0.14% | 0.34% | 2020-12-31 |
| CREDIT SUISSE AG/ | 291.73 tis | 0.20% | -0.02% | 0.06% | 2013-03-31 |
| RHUMBLINE ADVISERS | 284.21 tis | 0.20% | 0.00% | 0.06% | 2013-03-31 |
| WELLS FARGO & COMPANY/MN | 247.76 tis | 0.17% | 0.00% | 0.01% | 2011-12-31 |
| BANK OF MONTREAL /CAN/ | 234.33 tis | 0.16% | 0.00% | 0.02% | 2013-06-30 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 230.94 tis | 0.16% | 0.02% | 0.08% | 2013-03-31 |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 220.00 tis | 0.15% | 0.68% | 0.84% | 2013-06-30 |
Insider trading
| Jméno | Pozice | Typ transakce | Počet převedených akcií | Průměrná cena akcie | Datum | Počet držených akcií |
|---|---|---|---|---|---|---|
| Keeney Adam | officer: Head of Corporate Development | M-Exempt | 939 | 0.00 | 5.5 2026 | 0 |
| Keeney Adam | officer: Head of Corporate Development | F-InKind | 455 | 187.06 | 5.5 2026 | 6365 |
| Keeney Adam | officer: Head of Corporate Development | M-Exempt | 939 | 0.00 | 5.5 2026 | 6820 |
| Godbout Sean | officer: Chief Accounting Officer | M-Exempt | 181 | 0.00 | 3.4 2026 | 364 |
| Godbout Sean | officer: Chief Accounting Officer | F-InKind | 54 | 183.78 | 3.4 2026 | 1342 |
| Godbout Sean | officer: Chief Accounting Officer | M-Exempt | 181 | 0.00 | 3.4 2026 | 1396 |
| ALEXANDER SUSAN H | officer: EVP Chief Legal Officer | A-Award | 8450 | 0.00 | 17.2 2026 | 8450 |
| Godbout Sean | officer: Chief Accounting Officer | A-Award | 1800 | 0.00 | 17.2 2026 | 1800 |
| Gregory Ginger | officer: EVP, Human Resources | A-Award | 8025 | 0.00 | 17.2 2026 | 8025 |
| Grogan Jane | officer: Head of Research | A-Award | 8450 | 0.00 | 17.2 2026 | 8450 |
| Izzar Rachid | officer: Head of Global Product Strat. | A-Award | 7390 | 0.00 | 17.2 2026 | 7390 |
| Keeney Adam | officer: Head of Corporate Development | A-Award | 8025 | 0.00 | 17.2 2026 | 8025 |
| Kramer Robin | officer: Chief Financial Officer | A-Award | 8450 | 0.00 | 17.2 2026 | 8450 |
| Murphy Nicole | officer: Head of Pharm Ops and Tech | A-Award | 10560 | 0.00 | 17.2 2026 | 10560 |
| Murphy Nicole | officer: Head of Pharm Ops and Tech | P-Purchase | 3 | 195.04 | 17.2 2026 | 19611 |
| Singhal Priya | officer: Head of Development | A-Award | 10560 | 0.00 | 17.2 2026 | 10560 |
| Viehbacher Christopher | director, officer: President and CEO | A-Award | 38015 | 0.00 | 17.2 2026 | 38015 |
| ALEXANDER SUSAN H | officer: EVP Chief Legal Officer | M-Exempt | 2190 | 0.00 | 10.2 2026 | 0 |
| ALEXANDER SUSAN H | officer: EVP Chief Legal Officer | M-Exempt | 1940 | 0.00 | 10.2 2026 | 1940 |
| ALEXANDER SUSAN H | officer: EVP Chief Legal Officer | M-Exempt | 4916 | 0.00 | 10.2 2026 | 9834 |
| ALEXANDER SUSAN H | officer: EVP Chief Legal Officer | F-InKind | 1059 | 201.18 | 10.2 2026 | 37396 |
| ALEXANDER SUSAN H | officer: EVP Chief Legal Officer | F-InKind | 931 | 201.18 | 10.2 2026 | 38405 |
| ALEXANDER SUSAN H | officer: EVP Chief Legal Officer | M-Exempt | 2190 | 0.00 | 10.2 2026 | 38455 |
| ALEXANDER SUSAN H | officer: EVP Chief Legal Officer | M-Exempt | 1940 | 0.00 | 10.2 2026 | 39336 |
| ALEXANDER SUSAN H | officer: EVP Chief Legal Officer | F-InKind | 1514 | 201.18 | 10.2 2026 | 41807 |
| ALEXANDER SUSAN H | officer: EVP Chief Legal Officer | M-Exempt | 4916 | 0.00 | 10.2 2026 | 43321 |
| Godbout Sean | officer: Chief Accounting Officer | M-Exempt | 257 | 0.00 | 10.2 2026 | 0 |
| Godbout Sean | officer: Chief Accounting Officer | M-Exempt | 305 | 0.00 | 10.2 2026 | 305 |
| Godbout Sean | officer: Chief Accounting Officer | F-InKind | 76 | 201.18 | 10.2 2026 | 676 |
| Godbout Sean | officer: Chief Accounting Officer | M-Exempt | 257 | 0.00 | 10.2 2026 | 752 |
| Godbout Sean | officer: Chief Accounting Officer | F-InKind | 103 | 201.18 | 10.2 2026 | 878 |
| Godbout Sean | officer: Chief Accounting Officer | M-Exempt | 305 | 0.00 | 10.2 2026 | 981 |
| Godbout Sean | officer: Chief Accounting Officer | M-Exempt | 517 | 0.00 | 10.2 2026 | 1035 |
| Godbout Sean | officer: Chief Accounting Officer | F-InKind | 180 | 201.18 | 10.2 2026 | 1215 |
| Godbout Sean | officer: Chief Accounting Officer | M-Exempt | 517 | 0.00 | 10.2 2026 | 1395 |
| Gregory Ginger | officer: EVP, Human Resources | M-Exempt | 1635 | 0.00 | 10.2 2026 | 0 |
| Gregory Ginger | officer: EVP, Human Resources | M-Exempt | 1802 | 0.00 | 10.2 2026 | 1802 |
| Gregory Ginger | officer: EVP, Human Resources | M-Exempt | 3746 | 0.00 | 10.2 2026 | 7494 |
| Gregory Ginger | officer: EVP, Human Resources | F-InKind | 791 | 201.18 | 10.2 2026 | 18609 |
| Gregory Ginger | officer: EVP, Human Resources | M-Exempt | 1635 | 0.00 | 10.2 2026 | 19400 |
| Gregory Ginger | officer: EVP, Human Resources | F-InKind | 666 | 201.18 | 10.2 2026 | 19745 |
| Gregory Ginger | officer: EVP, Human Resources | M-Exempt | 1802 | 0.00 | 10.2 2026 | 20411 |
| Gregory Ginger | officer: EVP, Human Resources | F-InKind | 1132 | 201.18 | 10.2 2026 | 22359 |
| Gregory Ginger | officer: EVP, Human Resources | M-Exempt | 3746 | 0.00 | 10.2 2026 | 23491 |
| Grogan Jane | officer: Head of Research | M-Exempt | 1385 | 0.00 | 10.2 2026 | 1385 |
| Grogan Jane | officer: Head of Research | F-InKind | 407 | 201.18 | 10.2 2026 | 2769 |
| Grogan Jane | officer: Head of Research | M-Exempt | 1385 | 0.00 | 10.2 2026 | 3176 |
| Grogan Jane | officer: Head of Research | M-Exempt | 1873 | 0.00 | 10.2 2026 | 3747 |
| Grogan Jane | officer: Head of Research | F-InKind | 584 | 201.18 | 10.2 2026 | 4058 |
| Grogan Jane | officer: Head of Research | M-Exempt | 1873 | 0.00 | 10.2 2026 | 4642 |
| Izzar Rachid | officer: Head of Global Product Strat. | M-Exempt | 2044 | 0.00 | 10.2 2026 | 0 |
| Izzar Rachid | officer: Head of Global Product Strat. | M-Exempt | 1802 | 0.00 | 10.2 2026 | 1802 |
| Izzar Rachid | officer: Head of Global Product Strat. | M-Exempt | 3043 | 0.00 | 10.2 2026 | 6087 |
| Izzar Rachid | officer: Head of Global Product Strat. | F-InKind | 805 | 201.18 | 10.2 2026 | 7399 |
| Izzar Rachid | officer: Head of Global Product Strat. | M-Exempt | 2044 | 0.00 | 10.2 2026 | 8204 |
| Izzar Rachid | officer: Head of Global Product Strat. | F-InKind | 458 | 201.18 | 10.2 2026 | 8743 |
| Izzar Rachid | officer: Head of Global Product Strat. | M-Exempt | 1802 | 0.00 | 10.2 2026 | 9201 |
| Izzar Rachid | officer: Head of Global Product Strat. | F-InKind | 775 | 201.18 | 10.2 2026 | 11011 |
| Izzar Rachid | officer: Head of Global Product Strat. | M-Exempt | 3043 | 0.00 | 10.2 2026 | 11786 |
| Keeney Adam | officer: Head of Corporate Development | M-Exempt | 1802 | 0.00 | 10.2 2026 | 1802 |
| Keeney Adam | officer: Head of Corporate Development | F-InKind | 589 | 201.18 | 10.2 2026 | 3597 |
| Keeney Adam | officer: Head of Corporate Development | M-Exempt | 1802 | 0.00 | 10.2 2026 | 4186 |
| Keeney Adam | officer: Head of Corporate Development | F-InKind | 994 | 201.18 | 10.2 2026 | 5881 |
| Keeney Adam | officer: Head of Corporate Development | M-Exempt | 3278 | 0.00 | 10.2 2026 | 6557 |
| Keeney Adam | officer: Head of Corporate Development | M-Exempt | 3278 | 0.00 | 10.2 2026 | 6875 |
| Kramer Robin | officer: Chief Financial Officer | M-Exempt | 789 | 0.00 | 10.2 2026 | 0 |
| Kramer Robin | officer: Chief Financial Officer | M-Exempt | 703 | 0.00 | 10.2 2026 | 704 |
| Kramer Robin | officer: Chief Financial Officer | M-Exempt | 3511 | 0.00 | 10.2 2026 | 7024 |
| Kramer Robin | officer: Chief Financial Officer | F-InKind | 273 | 201.18 | 10.2 2026 | 8528 |
| Kramer Robin | officer: Chief Financial Officer | M-Exempt | 789 | 0.00 | 10.2 2026 | 8801 |
| Kramer Robin | officer: Chief Financial Officer | F-InKind | 207 | 201.18 | 10.2 2026 | 9024 |
| Kramer Robin | officer: Chief Financial Officer | M-Exempt | 703 | 0.00 | 10.2 2026 | 9231 |
| Kramer Robin | officer: Chief Financial Officer | F-InKind | 1063 | 201.18 | 10.2 2026 | 11472 |
| Kramer Robin | officer: Chief Financial Officer | M-Exempt | 3511 | 0.00 | 10.2 2026 | 12535 |
| Murphy Nicole | officer: Head of Pharm Ops and Tech | M-Exempt | 2102 | 0.00 | 10.2 2026 | 0 |
| Murphy Nicole | officer: Head of Pharm Ops and Tech | M-Exempt | 1940 | 0.00 | 10.2 2026 | 1940 |
| Murphy Nicole | officer: Head of Pharm Ops and Tech | M-Exempt | 4683 | 0.00 | 10.2 2026 | 9367 |
| Murphy Nicole | officer: Head of Pharm Ops and Tech | F-InKind | 1017 | 201.18 | 10.2 2026 | 15307 |
| Murphy Nicole | officer: Head of Pharm Ops and Tech | M-Exempt | 2102 | 0.00 | 10.2 2026 | 16324 |
| Murphy Nicole | officer: Head of Pharm Ops and Tech | F-InKind | 914 | 201.18 | 10.2 2026 | 16333 |
| Murphy Nicole | officer: Head of Pharm Ops and Tech | M-Exempt | 1940 | 0.00 | 10.2 2026 | 17247 |
| Murphy Nicole | officer: Head of Pharm Ops and Tech | F-InKind | 1408 | 201.18 | 10.2 2026 | 19608 |
| Murphy Nicole | officer: Head of Pharm Ops and Tech | M-Exempt | 4683 | 0.00 | 10.2 2026 | 21016 |
| Singhal Priya | officer: Head of Development | M-Exempt | 2217 | 0.00 | 10.2 2026 | 2217 |
| Singhal Priya | officer: Head of Development | F-InKind | 1056 | 201.18 | 10.2 2026 | 7432 |
| Singhal Priya | officer: Head of Development | S-Sale | 2660 | 199.83 | 10.2 2026 | 8043 |
| Singhal Priya | officer: Head of Development | M-Exempt | 2217 | 0.00 | 10.2 2026 | 8488 |
| Singhal Priya | officer: Head of Development | M-Exempt | 4683 | 0.00 | 10.2 2026 | 9367 |
| Singhal Priya | officer: Head of Development | F-InKind | 1412 | 201.18 | 10.2 2026 | 10703 |
| Singhal Priya | officer: Head of Development | M-Exempt | 4683 | 0.00 | 10.2 2026 | 12115 |
| Viehbacher Christopher | director, officer: President and CEO | M-Exempt | 9008 | 0.00 | 10.2 2026 | 9009 |
| Viehbacher Christopher | director, officer: President and CEO | F-InKind | 4356 | 201.18 | 10.2 2026 | 21095 |
| Viehbacher Christopher | director, officer: President and CEO | M-Exempt | 9008 | 0.00 | 10.2 2026 | 25451 |
| Viehbacher Christopher | director, officer: President and CEO | F-InKind | 6624 | 201.18 | 10.2 2026 | 29924 |
| Viehbacher Christopher | director, officer: President and CEO | M-Exempt | 15453 | 0.00 | 10.2 2026 | 30907 |
| Viehbacher Christopher | director, officer: President and CEO | M-Exempt | 15453 | 0.00 | 10.2 2026 | 36548 |
| Singhal Priya | officer: Head of Development | M-Exempt | 1829 | 0.00 | 3.2 2026 | 0 |
| Singhal Priya | officer: Head of Development | S-Sale | 748 | 179.30 | 3.2 2026 | 6271 |
| Singhal Priya | officer: Head of Development | F-InKind | 582 | 179.89 | 3.2 2026 | 7019 |
| Singhal Priya | officer: Head of Development | M-Exempt | 1829 | 0.00 | 3.2 2026 | 7601 |
